Immucor Forms Joint Venture with Kainos
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
TM Capital served as exclusive financial advisor to Sapheon Inc., a developer of venous disease treatments, in its sale to Covidien plc, a world leader in the treatment of peripheral vascular disease, for up to $238 million in cash and contingent consideration
TM Capital completed the sale by Reckitt & Colman plc (LSE) of its Glamorene® product lines to Joh. A. Benckiser GmbH
TM Capital advised leading global-IT services company AppLabs Technologies in its cross-border acquisition of IS Integration
TM Capital served as exclusive financial advisor to Pride Equipment Corporation in its $279 million sale to Sunbelt Rentals, a division of Ashtead Group plc
TM Capital assisted Frequency Electronics, Inc. (AMEX) in its strategic acquisition of Gillam s.a. of Belgium
TM Capital advised Octagon Process LLC, a leading supplier of de-icing chemicals for aircraft and runways, in its sale to Clariant Corporation, a major Swiss-based specialty chemical producer
TM Capital serves as exclusive financial advisor to Infrastructure & Industrial Constructors USA in its sale to Shikun & Binui America
TM Capital and its Swiss M&A International Inc. partner, Binder Corporate Finance, advised Datamars SA in the sale of a majority ownership stake of the Company to a group of private equity investors
TM Capital, together with our Oaklins partner Audon of Denmark, advised Bloomingville A/S in its sale to Creative Co-Op Inc.